Tiamulin Drugs Market: Introduction

  • Tiamulin is a pleuromutilin antibiotic drug that is used in veterinary medicine, particularly for pigs and poultry. It is also used for bacterial infection in animals. It is a semisynthetic derivative of the diterpene antibiotic pleuromutilin. Tiamulin is relatively quickly absorbed, metabolized in the liver, and eliminated from the body of the bird after a withdrawal period of 72 hours. Tiamulin is a crystalline powder that is available in soluble formulation in most countries in the world.

Key Drivers and Opportunities in Global Tiamulin Drugs Market

  • Rise in awareness about veterinary care has led to an increase in in animal health care practices. Changes in veterinary education over the last few decades have placed greater emphasis on animal welfare, owing to the rise in awareness about animal health care.
  • Government and private sector organizations are engaged in spreading awareness about importance of animal care and use of antibiotics in pig farms
  • Increase in demand for pork and poultry meat has led to a rise in poultry and pig farming. This is likely to propel the demand for antibiotic drugs, thereby driving the tiamulin drugs market.
  • Product approval is also likely to boost the tiamulin drugs market. For instance, in June 2020, the U.S. Food and Drug Administration approved Huvepharma’s Vetmulin 12.5% (tiamulin hydrogen fumarate) for the treatment of swine dysentery and swine pneumonia. In May 2020 Bimeda launched BimaGard 12.5% (tiamulin hydrogen fumarate) liquid concentrate for swine.
  • Overuse of tiamulin causes resistance to pathogens. This may limit the use of the product, thereby restraining the market. New drugs are approved on the basis of safety and efficacy regulations; however, stringent regulations enacted by governments may hamper industry players. Furthermore, new and more stringent regulations indirectly or directly impact the use of tiamulin drugs. Business is hampered by several factors including regulatory and legislative issues. Veterinary drug approval follows a process of human drug approval. The steps involved in approval process are discovery/concept, preclinical research, clinical research, FDA review, and FDA post-market safety monitoring.
  • Stringent government regulations contribute to the shortage of available drugs and slow decision making. This compels manufacturers to avoid research and development of new products and delay the approval process. In turn, this adversely affects the market.

North America to Capture Major Share of Global Tiamulin Drugs Market

  • North America is expected to account for major share of the global tiamulin drugs market during the forecast period due early adoption of new therapies and product approval. Supportive health care infrastructure is also likely to contribute to the growth of the market in region.
  • The tiamulin drugs market in Asia Pacific is expected to expand at a rapid pace during the forecast period owing to rise in awareness about veterinary care in the region

Key Players Operating in Global Tiamulin Drugs Market

The global tiamulin drugs market is highly concentrated due to the presence of key players. Large numbers of manufacturers hold major share of the market in their respective regions. Demand for antibiotic products has increased in emerging as well as developed markets. Growth strategies adopted by leading players are likely to drive the global tiamulin drugs market.

Major players operating in the global tiamulin drugs market are:

  • Fera Science Limited
  • Merck KGaA (Sigma-Aldrich)
  • Bimeda, Inc.
  • Huvepharma
  • Vetline

Global Tiamulin Drugs Market: Research Scope

Global Tiamulin Drugs Market, by Animal Type

  • Pigs
  • Poultry
  • Others

Global Tiamulin Drugs Market, by Route of Administration

  • Injectable
  • Oral

Global Tiamulin Drugs Market, by Target Pathogen

  • Gram-positive Bacteria
  • Mycoplasmas
  • Anaerobes
  • Others

Global Tiamulin Drugs Market, by Application

  • Swine Dysentery
  • Mycoplasma Arthritis
  • Others

Global Tiamulin Drugs Market, by Distribution Channel

  • Veterinary Hospitals
  • Retail Pharmacies
  • Online Pharmacies

Global Tiamulin Drugs Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Tiamulin Drugs Market

Pre Book